Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of cumulative dose administration of albuterol sulfate
inhalation aerosol delivered with valved holding chamber and facemask. This is a four week
study in birth to 23 month old subjects who are experiencing acute wheezing due to
obstructive airways disease.